Tixagevimab/cilgavimab prophylaxis against COVID-19 in solid organ transplant recipients: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Tixagevimab/cilgavimab prophylaxis against COVID-19 in solid organ transplant recipients: a systematic review and meta-analysis

Published:2024-06-21 Issue:2 Volume:38 Page:136-144
ISSN:3022-6783
Container-title:Clinical Transplantation and Research
language:en
Short-container-title:Clin Transplant Res

Author:

Khorramnia Saeed¹^ORCID,Navidi Zia¹^ORCID,Orandi Amirhossein²^ORCID,Iravani Mojgan Mohajeri³^ORCID,Orandi Amirali⁴^ORCID,Malekabad Ebadallah Shiri⁵^ORCID,Moghadam Seyed Hamid Pakzad¹^ORCID

Affiliation:

1. Department of Anesthesiology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran

2. Department of Anesthesiology, School of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

3. Department of Anesthesiology, Paramedical Faculty, Hajar Hospital, AJA University of Medical Sciences, Tehran, Iran

4. Department of Anesthesia and Critical Care, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran

5. School of Nursing, AJA University of Medical Sciences, Tehran, Iran

Publisher

The Korean Society for Transplantation

Link

https://pdf.medrang.co.kr/JKST/2024/038/ctr-38-2-136.pdf

Reference29 articles.

1. Excess Mortality Among Solid Organ Transplant Recipients in the United States During the COVID-19 Pandemic

2. The Higher COVID-19 Fatality Rate Among Kidney Transplant Recipients Calls for Further Action

3. SARS-CoV-2 Vaccination in Solid-Organ Transplant Recipients

4. Measures to Increase Immunogenicity of SARS-CoV-2 Vaccines in Solid Organ Transplant Recipients: A Narrative Review

5. Delayed exacerbation of COVID-19 pneumonia in vaccinated kidney transplant recipients receiving immunosuppressants: a case series